Hypothyroidism slows metabolic rate by 10-40%, making calorie restriction alone ineffective for many patientsGLP-1 therapy addresses this by reducing appetite and improving metabolic flexibility without forcing extreme dietary restriction
Patients with Type 2 diabetes face increased risks of myocardial infarction, stroke, and heart failure compared with the general population
FDAs career scientists have made clear they dont think theres enough data to support making peptides more widely available, specifically from compounding pharmacies, which mix customized medicines that arent available from traditional drugmakers
You still get appetite regulation, improved insulin sensitivity, and steady fat loss, but with significantly fewer side effects and a much lower risk of the muscle wasting that concerns people at higher doses
Sergey Terushkin, MD, FACS , who has extensive experience helping patients achieve their wellness and weight management goals through evidence-based treatment plans